PA
DERM

Parallel Advisors’s Dermira, Inc. DERM Stock Holding History

Parallel Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-346
Closed -$2.88K – 2460
2018
Q4 		$2K Hold
346
– – ﹤0.01% 1955
2018
Q3 		$4K Buy
346
+209
+153% +$2.11K ﹤0.01% 1854
2018
Q2 		$1K Buy
+137
New +$1.28K ﹤0.01% 2061

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parallel Advisors's DERM Position: Q1 2019 in Review

Parallel Advisors sold out of Dermira, Inc. (DERM) in Q1 2019, closing a stake of 346 shares — an estimated $2.88K sold.

Parallel Advisors first reported a position in DERM in Q2 2018 and held it in 3 quarters. The position peaked at $4K in Q3 2018. 144 funds tracked by Wall St. Rank hold DERM as of Q1 2019.

  • Parallel Advisors reported no remaining Dermira, Inc. position as of Q1 2019 after selling out during the quarter.
  • Parallel Advisors sold 346 Dermira, Inc. shares in Q1 2019, an estimated $2.88K.
  • Parallel Advisors first reported a position in Dermira, Inc. in Q2 2018 and held it in 3 quarters.
  • Parallel Advisors's Dermira, Inc. position peaked at $4K in Q3 2018.
  • 144 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2019.

Based on Parallel Advisors's 13F filing for Q1 2019, filed 1 May 2019.